Our hypotheses are that excitatory amino acids (EAA) play a major role in CNS control of cardiorespiratory function, and that derangements in EAA neurotransmission could result in cardiorespiratory disorders. We will test these hypotheses in anesthetized animals as well as in decerebrate animals by: 1) determining the role of EAA in tonic, CNS control, and in reflex and chemical control of cardiorespiratory activity by microinjecting either specific antagonists of EAA, EAA or drugs that inhibit the uptake of EAA into nerve terminals, into specific nuclei in the CNS circuitry controlling cardiorespiratory function while monitoring indices of cardiorespiratory activity; 2) determining whether alterations in the allosteric modulatory center influencing the N-methyl-D-aspartate (NMDA) receptor will alter cardiorespiratory activity; 3) using the intermediolateral cell column, the phrenic motor nucleus and the spinal cord nuclei containing motorneurons for the intercostal muscles; 4) using immunohistochemical cardiorespiratory activity, and to use immunohistochemistry combined with anterograde and retrograde tracing techniques to determine the origin and/or termination of these neurons;5) determining functional interactions between excitatory amino acid containing neurons and other neurotransmitter containing neurons controlling cardiorespiratory activity; and 6) beginning to use the information obtained by studies described in (1) through (5) to determine the role of EAA in causing derangements in cardiorespiratory function such as hypertension, obstructive sleep apnea and acute respiratory failure. As yet, EAA have not been implicated in derangements of cardiorespiratory function. However, because preliminary data indicate that EAA influence sites where the heaviest neural traffic enters and exits the CNS, and that the non-competitive NMDA antagonist, MK801, produces profound changes in cardiorespiratory function, it is clear that a study of EAA in CNS cardiorespiratory function will advance current knowledge in how the CNS controls cardiorespiratory function.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Wrathall, Jean R; Emch, Gregory S (2006) Effect of injury severity on lower urinary tract function after experimental spinal cord injury. Prog Brain Res 152:117-34
Teng, Yang Dong; Bingaman, Marian; Taveira-DaSilva, Angelo M et al. (2003) Serotonin 1A receptor agonists reverse respiratory abnormalities in spinal cord-injured rats. J Neurosci 23:4182-9
Wasserman, Adam M; Ferreira Jr, Manuel; Sahibzada, Niaz et al. (2002) GABA-mediated neurotransmission in the ventrolateral NTS plays a role in respiratory regulation in the rat. Am J Physiol Regul Integr Comp Physiol 283:R1423-41
Doherty, J; Gale, K; Eagles, D A (2000) Evoked epileptiform discharges in the rat anterior piriform cortex: generation and local propagation. Brain Res 861:77-87
Wasserman, A M; Sahibzada, N; Hernandez, Y M et al. (2000) Specific subnuclei of the nucleus tractus solitarius play a role in determining the duration of inspiration in the rat. Brain Res 880:118-30
Grossman, S D; Wolfe, B B; Yasuda, R P et al. (2000) Changes in NMDA receptor subunit expression in response to contusive spinal cord injury. J Neurochem 75:174-84
Sahibzada, N; Ferreira, M; Wasserman, A M et al. (2000) Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors. J Pharmacol Exp Ther 292:704-13
Masco, D; Sahibzada, N; Switzer, R et al. (1999) Electroshock seizures protect against apoptotic hippocampal cell death induced by adrenalectomy. Neuroscience 91:1315-9
Kozikowski, A P; Araldi, G L; Tuckmantel, W et al. (1999) 1-amino-APDC, a partial agonist of group II metabotropic glutamate receptors with neuroprotective properties. Bioorg Med Chem Lett 9:1721-6
Dunah, A W; Yasuda, R P; Luo, J et al. (1999) Biochemical studies of the structure and function of the N-methyl-D-aspartate subtype of glutamate receptors. Mol Neurobiol 19:151-79

Showing the most recent 10 out of 108 publications